Oncologic impact of statin use on patients treated with hepatectomy for intrahepatic cholangiocarcinoma
Statin therapy may be a potentially favorable medication for patients undergoing hepatectomy for ICC. However, further evaluation of its clinical benefits is required, and additional studies are recommended.
Authors
- Gi Hong Choi (ORCID: https://orcid.org/0000-0002-1593-3773)
- Dai Hoon Han (ORCID: https://orcid.org/0000-0003-2787-7876)
- Sung Hyun Kim (ORCID: https://orcid.org/0000-0001-7683-9687)
- Kyung Sik Kim (ORCID: https://orcid.org/0000-0001-9498-284X)
- Jin Sub Choi
- Sangheun Lee
- Jae Hwan Jeong
Institutions
- Yonsei University (KR)
- Catholic Kwandong University International St. Mary's Hospital (KR)
- Catholic Kwandong University (KR)
Publication Details
- Journal
- Hepatology Research
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1111/hepr.14205
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01